Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rankning i aktier #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aktiekurs
$0.2219522
Senast synkroniserad: 2025-09-11
Marknadsvärde
$1.10B
Förändring (1 dag)
0.04%
Förändring (1 år)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Aktiekurshistorik för Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Högsta slutkurs: $0.22 den 2025-09-01

Lägsta slutkurs: $0.37 den 1996-11-01
Aktiekurshistorik för Hubei Biocause Pharmaceutical Co., Ltd. från 1996 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.71%
2025 -66.20%
2024 62.74%
2023 -12.28%
2022 -9.28%
2021 -33.87%
2020 -20.96%
2019 13.63%
2018 -36.20%
2017 16.29%
2016 -30.41%
2015 159.71%
2014 42.61%
2013 1.59%
2012 -5.82%
2011 -41.89%
2010 45.21%
2009 108.27%
2008 -62.53%
2007 276.43%
2006 59.81%
2005 -25.60%
2004 -12.87%
2003 -63.90%
2002 -15.90%
2001 16.30%
2000 83.38%
1999 102.66%
1998 -18.77%
1997 -55.03%
1996 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$5.55 -6.02%
CN
$9.66 2.61%
HK
$43.69 42.17%
CA
$4.58 71.07%
TW
$96.59 18.72%
US